image below to play video interview with the Molecular Summit founder,
Robert Michel, of THE
MOLECULAR SUMMIT WEBSITE!
& Pathology's Most Important Summit On the Integration of Molecular
Imaging & Diagnostics
the most exciting intersection of genomic technologies in medicine
today! Innovators are pushing forward to integrate molecular imaging
and molecular diagnostics in ways that shift current paradigms in
patient care…and our Molecular Summit brings all the key players
together at one time and one place.
what you will find at Molecular Summit
• Meet global leaders forging forward with integrated diagnostics
services that combine imaging with molecular diagnostics.
• Hear 27 Top Speakers, Leaders, and Thinkers
• Hear how pioneers are combining molecular imaging and molecular
diagnostics to achieve remarkable patient outcomes.
• See emerging technologies at a unique exhibition with vendors
in radiology, pathology, and informatics.
• Explore how and why informatics will play a key role in fostering
the integration of molecular imaging and molecular diagnostics.
GENETIC KNOWLEDGE IS TRANSFORMING MOLECULAR
IMAGING AND MOLECULAR DIAGNOSTICS!
Experts declare it to be the most disruptive trend in healthcare today.
Yet radiology and pathology have yet to grasp the threats and opportunities
that lie ahead.
Many radiologists and pathologists remain unaware that corporate healthcare
giants such as Siemens and General Electric are investing billions
to reshape the diagnostic landscape. They've told Wall Street about
their respective plans to integrate in vivo and in vitro diagnostics.
But it's a business and clinical strategy that remains unknown to
those radiologists and pathologists who will be most affected.
That's been particularly true in recent months. Last May, General
Electric announced a joint venture with University of Pittsburgh Medical
Center (UPMC). Funded with $20 million from each partner, Omnyx,
LLC declared that it would have a fully digital pathology system
through regulatory approval and into the marketplace within 24 months.
In early October, Siemens announced an investment in BioImagene,
Inc., an emerging company that is selling digital imaging and
digital pathology services.
These recent actions by the world’s two largest imaging corporations
demonstrate how the forces of convergence are bringing molecular imaging
and molecular diagnostics together.
To help you understand this new vision for molecular imaging and molecular
diagnostics, we’ve assembled an international faculty of experts
and early adopters in radiology and pathology. On February 10-11,
2009, the international summit on integration of in vivo and in vitro
diagnostics took place in Philadelphia. You could have a front row
seat to learn how innovators are advancing clinical care and enhancing
their financial stability by incorporating the latest molecular imaging
techniques in tandem with emerging molecular diagnostics in 2011.
This may be the single most important event this year for your radiology
practice and pathology group. Ensure your success in molecular imaging
and diagnostics by reserving your place at the In Vivo/In Vitro Summit.
Molecular Summit is part of The
Dark Intelligence Group, Inc. and is dedicated to bringing useful
business and management intelligence to managers and administrators
of clinical diagnostic services, pathologists, radiologists, and industry
executives. Our recognized expertise in the strategic direction of
diagnostic medicine and the management of clinical diagnostics is
available through DARK Daily,
THE DARK REPORT, the Executive
War College on Laboratory and Pathology Management, Lab
Quality Confab, timely White
Papers, and strategic
Thanks to our past Corporate Benefactor
We're always ready to listen.
Email The Dark Report directly
Need specific information?
Let us help you. Read about our
Consulting and Other
The Dark Report
The Executive War College
Lab Quality Confab
Report Charter Memberships